投資評等
最後更新日期:2024/11/29
升級(Upgrade)
日期/Date | 券商 Brokerage Firm | 原評等->升級後評等 Upgrade from: -> to: | 新目標價 New Target |
2012/11/5 | MKM Partners | Neutral >> Buy | $47 >> $54 |
2011/4/5 | Wedbush | Neutral >> Outperform | $43 >> $47 |
2010/3/1 | Piper Jaffray | Neutral >> Overweight | |
2009/10/21 | KeyBanc Capital Mkts | Hold >> Buy | 37 |
2009/9/11 | Barclays Capital | Equal Weight >> Overweight | |
2005/4/26 | Janney Mntgmy Scott | Neutral->Buy | |
2004/4/1 | Caris & Company | Above Average->Buy | $25 |
2004/3/26 | Legg Mason | Hold->Buy | 61 |
2004/2/5 | Adams Harkness | Mkt Perform->Buy | 60 |
2003/6/11 | Goldman Sachs | In-Line -> Outperform | |
2003/1/31 | Lehman Brothers | Equal-weight -> Overweight | 45 |
降級(Downgrade)
日期/Date | 券商 Brokerage Firm | 原評等->降級後評等 Upgrade from: -> to: | 新目標價 New Target |
2015/4/13 | BB&T Capital Mkts | Buy >> Hold | |
2010/10/27 | KeyBanc Capital Mkts | Buy >> Hold | |
2010/10/27 | Oppenheimer | Outperform >> Perform | $41 >> $36 |
2010/7/20 | Wedbush | Outperform >> Neutral | $41 >> $35 |
2009/9/16 | Robert W. Baird | Outperform >> Neutral | |
2005/10/26 | Lehman Brothers | Overweight->Equal-weight | 46 |
2005/7/26 | Robert W. Baird | Outperform->Neutral | |
2005/5/19 | Janney Mntgmy Scott | Buy->Neutral | |
2004/11/3 | Legg Mason | Buy->Hold | |
2004/2/5 | Legg Mason | Buy->Hold | |
2003/10/16 | Goldman Sachs | Outperform -> In-Line | |
2003/9/5 | JP Morgan | Overweight -> Neutral | |
首次予以評等(Coverage Initiated)
日期/Date | 券商 Brokerage Firm | 原評等->升級後評等 Upgrade from: -> to: | 目標股價 |
2013/11/20 | Stifel | Buy | 80 |
2010/11/5 | MKM Partners | Neutral | |
2010/7/28 | Boenning & Scattergood | Outperform | 42 |
2010/6/16 | Boenning & Scattergood | Outperform | |
2010/3/26 | Wedbush | Outperform | 41 |
2009/11/2 | Longbow | Buy | 37 |
2009/8/11 | KeyBanc Capital Mkts | Hold | |
2009/3/25 | Barclays Capital | Equal Weight | |
2006/8/16 | Banc of America Sec | Neutral | 32 |
2005/11/30 | William Blair | Mkt Perform | |
恢復投資評等(Coverage Resumed)
日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
2015/10/12 | Goldman | Neutral | 53 |
2010/4/13 | FBR Capital | Mkt Perform | $36 >> $39 |
重申相同投資評等(Coverage Reiterated)
日期/Date | 券商 Brokerage Firm | 重申相同投資評等 Reiterated Rating | 新目標價 New Target |
2015/4/9 | Canaccord Genuity | Hold | $67 >> $63 |
2011/4/28 | FBR Capital | Mkt Perform | $38 >> $41 |
2011/4/27 | Longbow | Buy | $41 >> $45 |
2010/12/20 | Oppenheimer | Perform | $36 >> $39 |
2010/10/28 | FBR Capital | Mkt Perform | $40 >> $38 |
2010/10/15 | Longbow | Buy | $40 >> $39 |
2010/7/30 | Longbow | Buy | $41 >> $40 |
2010/7/30 | FBR Capital | Mkt Perform | $39 >> $40 |
2010/4/28 | Oppenheimer | Outperform | $36 >> $42 |
2010/3/31 | Ladenburg Thalmann | Buy | $40 >> $44 |